All Cancer articles – Page 38
-
-
NewsDelayed transfers of care at highest ever September level
There were 147,738 delayed transfers, the highest September level since 2010 A&Es had their worst September performance in five years as admissions were at highest level Increase in elective patients waiting over a year to start treatment but the target was still met Delayed transfers of care were ...
-
NewsHSJ annual lecture: Hunt promises new 'Ofsted style ratings' for CCGs
Ofsted style ratings are to be given to each area of the country for performance in a range of clinical areas including cancer, dementia and mental health, Jeremy Hunt will announce today at HSJ’s annual lecture.
-
-
-
NewsCarter review: Top surgeon to tackle clinical and cost variation
The government’s newly appointed quality tsar will work with Lord Carter’s team to drive out ‘unwanted variation’ in clinical practice across the NHS, it has announced.
-
HSJ LocalUpdated: Hospital rebuild set to drive shake up of city's blood cancer services
STRUCTURE: Commissioners have agreed to help fund a £36m extension to a new cancer hospital being built in Liverpool, to make possible a reconfiguration of the city’s fragmented blood cancer services.
-
NewsStevens hires national leads for specialised, primary and cancer care
NHS England has appointed Jonathan Fielden and Arvind Madan to lead its work on specialised services and primary care respectively.
-
-
HSJ LocalCharitable funds pay for trust’s breast cancer imaging system
FINANCE: A £70,000 imaging system has been installed in operating theatres at Scunthorpe Hospital to allow surgeons to X-ray breast tissue during operations.
-
-
-
NewsMapped: Acute care vanguards revealed
Thirteen bids have been chosen to take forward NHS England’s vanguard for future models of acute care.
-
Supplements
Value in Healthcare Awards: Implementation of IT to Support Healthcare Business Efficiency
Value in Healthcare Awards winners for 2015
-
-
CommentCuts in cancer spending expose a funding challenge
There will be tough choices over cash and cancer
-
NewsHigh profile treatments cut from cancer drugs fund
High profile cancer treatments including Roche’s Kadcyla and Avastin are to be removed from the cancer drugs fund.
-
-
NewsDrug pricing deal change 'cuts NHS England's ability to provide care'
NHS England faces a ‘direct cut’ in its ability to provide care to patients as a result of a change to the deal that caps the price the government pays for branded medicines, a senior health economist has said.
-
NewsBacklash expected over cancer drugs delisting
Talks are under way to identify high profile treatments to be removed from the cancer drugs fund in the coming months, HSJ has learned.